The elimination of secretory leukocyte protease inhibitor (SLPI) from the gastrointestinal tract in man

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 57, Issue 2, 1997, Pages 119-125

  Nystrom M ^a   Bergenfeldt, M ^a   Ohlsson, K ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

inflammatory bowel disease; pepsin; protease inhibitor; SLPI

Indexed keywords

IODINE 125; RECOMBINANT PROTEIN; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR;

ARTICLE; BLOOD LEVEL; DEGRADATION; DUODENUM FLUID; EXCRETION; FECES; GASTROINTESTINAL TRACT; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; NORMAL HUMAN; PRIORITY JOURNAL; RADIOACTIVITY; STOMACH JUICE; TURNOVER TIME; URINARY EXCRETION; VOLUNTEER;

SUIDAE;

EID: 0030970708     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365519709056379     Document Type: Article

References (27)

1. Thompsson RC, Ohlsson K. Isolation, properties and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte protease. Proc Natl Acad Sci USA 1986; 83: 6692-6.
2. Ohlsson K, Rosengren M, Stetler G, Brewer M, Hale KK, Thompsson RC. Structure, genomic organization, and tissue distribution of human secretory leukocyte protease inhibitor (SLPI): a potent inhibitor of neutrophil elastase. In: Taylor JC, Mittman C, editors. Pulmonary emphysema and proteolysis. London: Academic Press, 1986: 307-22.
3. Tegner H, Ohlsson K, Olsson I. The interactions between a low molecular weight protease inhibitor of bronchial mucus and chymotrypsin-like cationic proteins of granulocytes. Hoppe-Seyler's Z Physiol Chem 1977; 350: 431-3.
4. Moreen HWD, Kramps JA, Franken C, Meijer CJLM, Dijkman JA. Localization of a low-molecular-weight bronchial protease inhibitor in the peripheral human lung. Thorax 1983; 38: 180-3.
5. Abe T, Kobayashi N, Yoshimura K, Trapnell BC, Kim H, Hubbard RC, et al. Expression of the secretory leukoprotease inhibitor gene in epithelial cells. J Clin Invest 1991; 87: 2207-15.
6. Casslen B, Rosengren M, Ohlsson K. Localization and quantification of a low molecular weight proteinase inhibitor, antileukoprotease, in the human uterus. Hoppe-Seyler's Z Physiol Chem 1981; 362: 953-61.
7. Wallner O, Fritz H. Characterization of an acid stable proteinase inhibitor in human cervical mucus. Hoppe-Seyler's Z Physiol Chem 1974; 355: 709-15.
8. Ohlsson M, Rosengren M, Tegner H, Ohlsson K. Quantification of granulocyte elastase inhibitors in human mixed saliva and in pure parotid secretion. Hoppe-Seyler's Z Physiol Chem. 1983; 364: 1323-8.
9. Fink E, Jaumann E, Fritz H, Ingrish H, Werle E. Isolierung durch affinitätschromatographie und hemmverhalten. Hoppe-Seyler's Z Physiol Chem 1971; 352: 1591-4.
10. Ohlsson K, Bjartell A, Lilja H. Secretory leukocyte protease inhibitor in the male genital tract: PSA-induced proteolytic processing in human semen and tissue localization. J Androl 1995; 16: 64-73.
11. Franken C, Meijer CJLM, Dijkman JH. Tissue distribution of antileukoprotease and lysozyme in humans. J Histochem Cytochem 1989; 37: 493-8.
12. Bohm B, Deutzmann R, Burkhardt H. Purification of a serine-proteinase inhibitor from human articular cartilage. Identity with the acid-stable proteinase inhibitor of mucous secretions. Biochem J 1991; 274: 269-73.
13. Ohlsson K, Tegner H. Inhibition of elastase from granulocytes by the low molecular weight bronchial protease inhibitor. Scand J Clin Lab Invest 1976; 36: 437-45.
14. Vogelmeier C, Hubbard R, Fells G, Schnebli H-P, Thompsson R, Fritz H, et al. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor. J Clin Invest 1991; 87: 482-8.
15. Birrer P, McElvaney NG, Gillissen A, Hoyt RF, Bloedow DC, Hubbard RC, et al. Intravenous recombinant secretory leukoprotease inhibitor augments antineutrophil elastase defense. J Appl Physiol 1992; 73: 317-23.
16. Fink E, Nettelbeck R, Fritz H. Inhibition of mast cell chymase by eglin c and antileukoprotease (HUSI-I) Biol Chem Hoppe-Seyler 1986; 367: 567-71.
17. Bergenfeldt M, Ohlsson K. Protease-antiprotease levels and whole-blood chemiluminiscence in acute peritonitis. Gastroenterol Japon 1993; 28: 687-98.
18. Bergenfeldt M, Nyström M, Bone M, Lindström M, Polling A, Ohlsson K. Localization of immunoreactive secretory leukocyte protease inhibitor (SLPI) in intestinal mucosa. J Gastroenterol 1996; 31: 18-23.
19. Schiessler H, Arnhold M, Ohlsson K, Fritz H. Inhibitors of acrosin and granulocyte proteinases from human genital tract secretions. Hoppe-Seyler's Z Physiol Chem 1976; 357: 1251-60.
20. Baugh RJ, Travis J. Human leukocyte granulate elastase: rapid isolation and characterization. J Biochem 1976; 15: 836-41.
21. Fraker PJ, Speck JC. Protein and cell membrane iodinations with a sparingly soluble chloramide, 1,3,4,6-tetrachloro-3a, 6a-diphrenylglucoluril. Biochem Biophys Res Commun 1978; 80: 849-57.
22. Bieth J, Spiess B, Wermuth CG. The synthesis and analytical use of a highly sensitive and convenient substrate of elastase. Biochem Med 1974; 11: 350-7.
23. 4. Nature 1970; 227: 680-5.
24. Ohlsson M, Rosengren M, Tegner H, Ohlsson K. Quantification of granulocyte elastase inhibitors in human mixed saliva and in pure parotid secretions. Hoppe-Seyler's Z Physiol Chem 1983; 364: 1323-28.
25. Lee CH, Igarashi Y, Hohman RJ, Kaulbach H, White MV, Kaliner MA. Distribution of secretory leukoprotease inhibitor in the human nasal airway. Am Rev Respir Dis 1993; 147: 710-16.
26. Geigy scientific tables. Units of measurement, body fluids, composition of the body, nutrition. 1982: 114.
27. Fryksmark U, Jannert M, Ohlsson K, Tegner H Wihl J-Å. Secretory leukocyte protease inhibitor in normal, allergic and virus induced nasal secretions. Rhinology 1989; 27: 97-103.